Trends in charges and payments for nonhospitalized emergency department pediatric visits, 1996-2003

Renee Y Hsia1, Donna MacIsaac, Erin Palm

  • 1San Francisco General Hospital, University of California at San Francisco, San Francisco, CA, USA. rhsia@sfghed.ucsf.edu

Insights

Pediatric emergency department reimbursements declined significantly from 1996 to 2003 for all insurance types. Medicaid/State Children's Health Insurance Program (SCHIP) consistently showed the lowest reimbursement rates.

Area of Science:

  • Health Economics
  • Pediatric Healthcare Policy
  • Reimbursement Analysis

Background:

  • Outpatient pediatric emergency department (ED) visits are a critical component of child healthcare.
  • Understanding financial trends in ED reimbursements is essential for healthcare providers and policymakers.
  • Previous analyses have not fully detailed reimbursement trends across diverse payer groups for pediatric ED visits.

Purpose of the Study:

  • To compare charges and payments for pediatric outpatient emergency visits across different payer groups.
  • To provide insights into reimbursement trends for pediatric emergency care.
  • To analyze financial dynamics affecting pediatric ED services.

Main Methods:

  • Utilized data from the Medical Expenditure Panel Survey (1996-2003).
  • Analyzed total charges and payments for emergency department visits among Medicaid/State Children's Health Insurance Program (SCHIP), privately insured, and uninsured pediatric patients.
  • Employed regression analysis to adjust for patient characteristics and track average charges and payments per visit.

Main Results:

  • Pediatric ED visit charges increased from 1996 to 2003, but payments did not keep pace, leading to a decline in overall reimbursement rates from 63% to 48%.
  • Medicaid/SCHIP visits consistently exhibited the lowest reimbursement rates, falling to 35% in 2003.
  • The proportion of pediatric ED visits covered by Medicaid/SCHIP increased during the study period.

Conclusions:

  • Reimbursements for pediatric outpatient ED visits decreased across all payer groups (public, private, uninsured) between 1996 and 2003.
  • Medicaid/SCHIP consistently provided lower per-visit payments compared to private and uninsured categories.
  • Further investigation into the financial impact of declining reimbursements on pediatric ED services is necessary.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VII: EMR01:30

Methods of Documentation VII: EMR

Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare settings,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...